The Disciplinary Committee heard three charges against Dr Dhami, relating to events which took place while he was in practice at Vets4Pets in Market Harborough, Leicestershire.
The first charge against him was that, in November 2017, he used excessive force in kicking and stamping on a Staffordshire Bull Terrier he was treating.
The second charge was that, between in October and November 2017, he failed to pay adequate regard to the welfare of a Jack Russell in his care by leaving it in a sink without adequate reason and for an excessive period of time.
The third charge was that, between April and March 2018, he failed to have adequate regard to the welfare of a six-to-eight week old kitten, including providing bedding and warmth.
At the outset of the hearing Dr Dhami admitted to lightly kicking the dog, but denied forcefully kicking it and also denied that he had stamped on the dog, as well as denying the other two charges against him.
In considering the circumstances of the first charge, the Committee heard evidence from two of Dr Dhami’s colleagues stating that the dog had bitten him whilst he was cleaning its ears and, following this, he took the dog out of the consulting room, closed the door and whilst holding the dog’s lead then proceeded to kick her twice, knocking her along the floor both times, and then finally stamp on her when she was prone.
Dr Dhami disputed his colleagues' version of events and stated that he had only delivered two light kicks to the dog’s rump, that neither of these had made her fall to the floor and also denied in categorical terms that he stamped on the animal. Furthermore, he also denied the second and third charges against him.
In considering the evidence as to whether Dr Dhami kicked and stamped on the dog, the Disciplinary Committee found the evidence of his two colleagues to be credible and reliable, and so found all aspects of the charge proven.
Ian Green, chairing the Committee and speaking on its behalf, said: "For the avoidance of doubt, the Committee finds that the admitted kicks administered to [the animal] by the respondent were of significant force. The Committee rejects the respondent’s assertion that the admitted kicks amounted to mere taps on the backside. The Committee finds that the ‘stamping’ was also of significant force."
In regards to the second and third charges, the Committee was not satisfied that the charges had been proven by the evidence it heard and therefore dismissed them both.
Having found all parts of the first charge proven, the Committee then went on to consider whether or not Dr Dhami’s conduct amounted to serious professional misconduct, something that Dr Dhami, following the Committee’s decision on the facts, through his counsel, had admitted.
The Committee identified a number of aggravating factors, including the real risk of physical harm to the animal and the deliberate nature Dr Dhami’s conduct against the animal, committed in anger.
In mitigation, the Committee accepted that this was an isolated incident and that Dr Dhami had been bitten and was in pain. The Committee therefore found that Dr Dhami’s admission of serious professional misconduct was ‘properly and prudently made’.
The Committee then considered what sanction to impose on Dr Dhami. In doing so it took into account some of the written testimonials and character witnesses called on behalf of Dr Dhami. The Committee was also satisfied that Dr Dhami had had a hitherto long and unblemished career, that he had apologised to colleagues immediately after the incident and that, since the events, he had continued to work as a veterinary surgeon without any problems.
In relation to insight about the event, the Committee accepted Dr Dhami had provided some evidence of reflection, in that he admitted kicking the dog and accepted that this conduct, once found proven, amounted to serious professional misconduct.
The Committee decided that suspending Dr Dhami from the Register for four months would be the most proportionate sanction.
Ian Green concluded: "Having regard to all the matters urged by way of mitigation, and having taken into account all the evidence that it has heard, the Committee is satisfied that a period of suspension is sufficient in this case to protect the welfare of animals, maintain public confidence and to declare and uphold proper standards of conduct."
Dr Dhami has 28 days from being informed of the outcome of the hearing in which to make an appeal to the Privy Council.
The company points to a study which showed that cats treated Bravecto Plus showed no visible signs of mites at 14 days and 100% efficacy was confirmed at 28 days1. This, says the company, means that Bravecto Plus now gives 12 week control of fleas and ticks, eight week prevention of heartworm disease, treatment of roundworm and hookworm, and treatment of ear mites.
Hannah Newbury, Companion Animal Technical Lead at MSD Animal Health said: "With 1 in 4 cats in the Big Flea Project study having fleas2, we can conclude that pet owner compliance to parasite prevention is currently poor.
"This new licence is an important development for vets and cat owners, offering greater convenience, while helping improve flea and tick compliance. Bravecto Plus builds on the qualities of Bravecto and offers vets and cat owners another tool in the fight against an even broader range of potentially harmful parasites.
"Research by MSD Animal Health shows that 82% of cat owners believe that the ideal flea and tick treatment lasts longer than 2 months3 and vets can offer their cat owners this and more with BRAVECTO PLUS due to its 12 week duration of activity4.
For further information contact your MSD Animal Health Account Manager.
References
Amy Scott MRCVS, Boehringer Ingehlheim’s performance horse portfolio manager, said: "Arti-Cell Forte is the first 'ready-to-use' stem cell-based product to be licensed in any veterinary species, and the only stem cell treatment to contain induced cells, representing a significant leap forward in both stem cell therapies and medicine as a whole.
"Arti-Cell Forte contains stem cells that have been chondrogenically induced and therefore primed to develop into the cartilage cell lineage. Studies have shown that chondrogenically induced stem cells demonstrate an enhanced clinical outcome compared to un-induced stem cells in the treatment of joint disease in horses¹."
"This makes Arti-Cell Forte a highly targeted and effective treatment for cartilage damage associated with degenerative joint disease."
Arti-Cell Forte is available direct from Boehringer Ingelheim to veterinary practitioners.
It needs to be stored at ultra-low temperatures to maintain its two year shelf life from manufacture, either frozen at -70 ⁰C to -90 ⁰C (dry ice, -80 ⁰C freezer) or -196 ⁰C (liquid nitrogen) until immediately prior to injecting.
The company is providing full training on storage and administration via face-to-face CPD at practice meetings or specific CPD events*.
For more information, contact your local territory manager or ring Boehringer's Technical Services Team on 01344 746957, or email vetenquiries@boehringer-ingelheim.com
Reference
The Disciplinary Committee had found Dr Schulze Allen guilty of four charges, namely that he had been convicted of the criminal offence of petty theft in the US which rendered him unfit to practise, and that on three subsequent occasions, twice to the RCVS and once to a notary in California, dishonestly represented that he had no criminal convictions.
Following the DC hearing, Dr Schulze Allen submitted an appeal to the Privy Council. The basis of his appeal revolved around whether, under Californian law, his conviction for petty theft was a conviction for a criminal offence or an infraction, and whether an infraction under US law was a criminal offence.
The RCVS had argued that while the theft is not a criminal felony in California, it would be considered so under English law.
However, the Board of the Privy Council which heard the appeal – comprising Lords Wilson, Carnwath and Lloyd-Jones, found the College had not proven beyond all reasonable doubt that Dr Schulze Allen was convicted of a criminal offence under Californian law. It therefore upheld his appeal against the DC’s finding that he had committed a criminal offence.
The Privy Council then considered Dr Schulze Allen’s appeal against the third and fourth of the charges against him - that he was dishonest in his representations to the College that he did not have a ‘criminal’ conviction and did not have a ‘criminal record’. The Privy Council found that, since the conviction for petty theft was an infraction, and was not a criminal offence and did not leave Dr Schulze Allen with a criminal record, then, strictly speaking, his representations to the RCVS were not false and so upheld his appeal against these two charges.
The Privy Council then considered Dr Schulze Allen’s appeal against the College’s second charge against him. This charge was that he had, in a written application for restoration to the Register, represented that he did not have any cautions, criminal convictions or "adverse findings". The College argued that he still had a responsibility to make a full and frank disclosure about his infraction, even if it did not meet the threshold of ‘criminal’ under Californian law.
The Board of the Privy Council said it had, on Dr Schulze Allen’s behalf, done its best to identify some argument that his conviction for a petty theft infraction did not amount to an "adverse finding", but failed. Rather, it found that "the conviction obviously amounted to an adverse finding."
The Board added that "there is no material by reference to which the Board [of the Privy Council] can depart from the [Disciplinary] Committee’s conclusion that, in answering “no” to that question, he knew that his answer was untrue. In other words, his denial was dishonest."
The Board therefore allowed the appeal against the DC’s conclusion on the first, third and fourth charges. But it dismissed the appeal against its conclusion on the second charge, namely that in that regard Dr Schulze Allen had been guilty of disgraceful conduct in a professional respect."
The Board then set aside the original sanction, that Dr Schulze Allen be removed from the Register, and tasked the Committee with identifying the appropriate sanction in relation to the second charge.
The Disciplinary Committee will now hold a further hearing to decide the sanction, at some time in the future. In the meantime Dr Schulze Allen remains on the Register of Veterinary Surgeons.
Vetemex has a 56-day broached shelf life and uses benzyl alcohol as the excipient, rather than metacresol.
Virbac points to a study in which benzyl alcohol achieved a 78% reduction in pain score immediately post-injection, and a 53% reduction in pain score in the 2-minute period post-injection, compared to Metacresol1.
Vetemex is presented in a 20ml bottle and is available from the veterinary wholesalers now.
Claire Lewis, Product Manager at Virbac said: "Vetemex is a valuable addition to the already extensive Virbac portfolio. We are pleased to be able to offer vets this new, and more comfortable to administer, antiemetic option."
For more information on Vetemex, speak to your Virbac Territory Manager.
The charity says that although histiocytic sarcoma is rare, it is an aggressive form of cancer which Flatcoated Retrievers are particularly susceptible to.
According to the AHT, almost half of all affected Flat-coated Retrievers will have a tumour in multiple locations in the body at the time of diagnosis. The outlook for these dogs is very poor and, in most cases, means they receive a terminal diagnosis.
The new research revolves around microRNAs, abnormal levels of which are often found in tumours. In addition, different microRNAs are involved in different cancers. These cancer-specific microRNA signatures can be found within the blood of cancer patients, meaning that a tumour could potentially be diagnosed with a blood test.
To start with, the researchers say they plan to confirm if there is a specific microRNA signature that is unique to histiocytic sarcomas amongst tumours and normal tissue samples from Flatcoated Retrievers. If a signature is identified, the project will investigate if measuring the levels of these microRNAs within a Flatcoated Retriever tissue sample can be used to accurately identify a histiocytic sarcoma. If it can, additional funding will be sought for more research to identify if the microRNA signature is also detectable in the blood of affected dogs, and thence to develop a blood test.
If it comes off, this would mean that a blood sample from a Flatcoated Retriever that was lame, or was showing non-specific clinical signs of the disease such as depression, lethargy, appetite or weight loss, could be tested for the presence of the histiocytic sarcoma-associated microRNAs.
A dog with a positive test result could then have an early MRI scan and histopathology done to confirm the diagnosis, hopefully at a stage where treatment would be more successful.
Dr Anna Hollis, cancer researcher at the Animal Health Trust, said: "I have Flatcoated Retrievers and have lost one of them to histiocytic sarcoma - it is absolutely devastating. This research could make a significant difference, and that is a huge personal motivation for me. Histiocytic sarcoma is a particularly tricky cancer to diagnose, because the tumours are frequently located deep within or between the muscles of the upper limbs - underneath the shoulder is a common location.
"Often lame dogs are rested and given pain relief before imaging is sought. Delayed diagnosis is a potential problem with histiocytic sarcoma given its aggressive nature and ability to spread rapidly to other locations within the body. If we could identify affected dogs at an earlier stage, this may allow more successful treatment of the disease."
The research project has been funded by the Flatcoated Retriever Society (FCRS) and the FCRS Rescue, Rehousing and Welfare Scheme. The Flatcoated Retriever Breed Health Co-ordinator, Liz Branscombe, said "Sadly, there is a high incidence of this aggressive form of cancer in our beautiful breed. Early detection of the disease is key in optimising cancer treatment and prolonging survival time so the prospect of a diagnostic blood test for use in the future is exciting.'
Photo: Liz Branscombe, Dr Mike Starkey and Dr Anna Hollis of AHT and Brian Jones of FCRS Rescue, Rehousing and Welfare.
The company says the new test overcomes a major shortcoming in faecal egg counts: that they can only detect the presence of egg-laying adult worms. The new test, by contrast, can detect all stages of the small redworm life cycle, including the important encysted larval phase.
ADB says the new test will help protect the effectiveness of moxidectin, the only dewormer which is capable of eliminating the encysted stages and against which widespread resistance is not thought to have developed.
Whereas before, routine winter treatment was needed to target the encysted phase, this new test means the drug can be kept for when it is really needed, which will help prevent the development of resistance. ADB says it will also be of great value to equine vets in making differential diagnoses.
The blood test was developed by Prof Jacqui Matthews’ group at the Moredun Research Institute (MRI), with funding from The Horse Trust. She said: "It is great to see the commercialisation of this much-needed test to support sustainable worm control in horses. The test fills an important gap in our diagnostic toolbox and will enable horse owners to work with their veterinarians in targeting anthelmintic treatments against cyathostomin infections and hence help protect these important medicines for the future."
Dr Corrine Austin from ADB said: "ADB is now developing laboratory ELISA kits to enable independent veterinary laboratories to conduct blood testing; these kits are expected to reach market during 2020. Research into the saliva-based test is ongoing and is expected to be commercialised several years from now."
Veterinary practices can contact ADB at info@austindavis.co.uk to register interest in the diagnostic test service.
The poster grades faeces from one (kickable) to six (most certainly not kickable).
James Kyffin, Veterinary Director at Protexin Veterinary said: "We believe that Poop Points offers pet owners a fun and engaging way to monitor their pet’s faeces."
That, surely, must win James the "Oxymoronic Veterinary Quote of the Year Award 2019".
More seriously, he went on to say: "It is important to raise awareness of alterations in animal’s faecal scores and ensure that this is communicated to their veterinary surgeon in an effective way."
Practices in the UK and Ireland can order their free poster on Protexin's website: https://www.protexinvet.com/pooppoints, or by emailing info@protexin.com.
Protexin will also be promoting digestive health advice on its website and social channels (@Protexin Veterinary on Facebook and Instagram), which practices can share and use.
The Case Reports session has been devised by BSAVA’s programme committee to support RVNs who want to develop their presenting ability. It is specifically aimed at those with little or no experience of presenting and includes mentorship support for the selected candidates.
Claire Woolford RVN VTS (Anaesthesia), who sits on the BSAVA Congress Programme Committee said: "Case reports represent an engaging and interactive method for nurses to discuss unique cases or new techniques. What’s particularly special about the initiative at Congress 2020, is that we want to use the case report platform to support aspiring veterinary nurse speakers who could become speakers at Congress or other BSAVA events.
"We are particularly encouraging nurses with limited experience of presenting and offering the positive environment of Congress for them to develop their skills. All successful candidates will be assigned an experienced mentor who will aid them in preparing the final report to present at Congress."
A total of 8 winning applicants will be selected by the BSAVA Congress programme committee to present their case report. Each successful applicant will be given a 15-minute slot to present at Congress 2020, together with a complimentary Congress nurse pass for the whole of Congress for BSAVA VN members, or for Saturday 4 April for non-members. The presenter of the best case will also be awarded a BSAVA Manual of their choice.
For a chance to be involved, BSAVA is asking nurses to submit a brief synopsis of their case by 4th November 2019. The Case Report must focus on small animal cases, but any species and discipline can be discussed. Full submission information is available at www.bsavaevents.com
The Osurnia Ear Health Hub includes information about the treatment of canine otitis externa from dermatologists Sue Paterson and Natalie Barnard, advice about responsible antibiotic use, expert tips for vets to use in the consulting room and dog owner educational materials that veterinary staff can use in practice and online. It will also include a podcast interview with Sue.
The hub also provides information, videos and research about Osurnia.
Elanco Animal Health UK Marketing Manager, Rebecca Bryant said: "We know all too well the challenges vets face when treating canine OE and the significant impact the condition has on the quality of life of both the dog and the owner.
"The Osurnia Ear Health Hub is a new disease resource hub on MyElanco, which provides helpful resources for veterinary professionals looking for answers or to enhance their understanding of the disease. We hope that with more easily accessible information, this will help vets to treat OE cases and communicate with their clients."
Visit the canine ear health hub at: www.myelanco.co.uk
Whilst on the subject of information resources, this one has come to my attention. It's a list of other veterinary blogs and information resources: https://blog.feedspot.com/veterinary_blogs.
Encouragingly, 88% of the 5046 people surveyed said they keep guinea pigs in groups of two or more, as is recommended by experts and, in fact, required by law in Switzerland. 88% also said they provide their guinea pig with additional space to roam outside of their housing.
Although only 3% of guinea pig owners said they insure their pet, 67% said they take their guinea pig to see the vet once a year or more.
When it comes to nutrition, 76% of owners say they believe feeding hay is the most important part of their guinea pig(s) diet and 65% say it is their guinea pigs’ primary food source. Burgess says that in an ideal world 100% of guinea pigs would be fed hay as their primary food source, so 65% shows there is room for improvement.
Peter Lancaster, marketing manager at Burgess Pet Care said: "Guinea pigs make fantastic pets but, as with other small animals, they have very particular needs when it comes to their welfare. Thankfully, according to the findings of our census, we found that the majority of guinea pig owners who provided answers on the five welfare needs – diet, company, health, environment and behaviour, are conscientious with their care, reflecting their dedication to keeping their pets happy.
"It was fantastic to see the number of guinea pig owners entering the census keep rising by the day, and we’re reassured that there are thousands of well-informed owners out there. However, despite these resoundingly positive findings, there is always work to be done when it comes to improving standards of animal welfare. The information we’ve received from this census does identify the gaps of knowledge in certain areas, and we anticipate these gaps to be much larger when it comes to less-informed and engaged guinea pig owners."
There are only 11 other practices in the UK that hold the Gold Standard Award for rabbit care. To achieve it, Valley Veterinary Hospital had to demonstrate excellence across all aspects of rabbit care, including pain relief and management, dentistry and airway management.
The practice was commended on its top-quality facilities, including a dedicated exotic department with separate waiting and consulting rooms, as well as kennel areas for rabbits to keep them away from larger animals, relieving them of stress and anxiety.
Valley Veterinary Hospital exotic animals specialist, Tariq Abou-Zahr, BVSc CertAVP(ZooMed) MRCVS (pictured right), said: "I am absolutely delighted that Valley Veterinary Hospital has met the grade to achieve the first RWAF gold status in Wales. I believe that rabbits are just as deserving of excellent veterinary care as cats and dogs, and I am so pleased that I work in a veterinary hospital where we have the facilities to provide this standard of care.
"Rabbit medicine has always been an interest of mine, and I’m very grateful to Vet Partners for investing in such great facilities and to RWAF for considering our application and granting us Gold status."
Applications for the Awards are assessed by Dr Richard Saunders BSc Hons MSB CBiol DZooMed MRCVS, one of the UK’s leading specialists on rabbit welfare and veterinary advisor for RWAF.
Dr Richard Saunders BSc Hons MSB CBiol DZooMed MRCVS, who assesses applications on behalf of the RWAF, said:
"As a dedicated rabbit charity aiming to improve the wellbeing and welfare of domestic rabbits throughout the UK, our requirements to meet a Gold standard in rabbit care are very high. Valley Vets has met all of these standards and I’m delighted to reward a practice in Wales who have demonstrated that they are as passionate about rabbit care as we are.”
The RWAF has published a list of award-winning rabbit-savvy practices on its website which can be viewed here: https://rabbitwelfare.co.uk/rabbit-care-advice/rabbit-friendly-vets/rabbit-friendly-vet-list/
Any veterinary practices interested in applying for the Rabbit Friendly Vet List should visit https://rabbitwelfare.co.uk/rabbit-vets/vet-membership/
The Disciplinary Committee heard three charges against Dr Jones.
The first and second charges were that, in March 2018, Dr Jones made signed entries in the passports and made corresponding entries in clinical records of four horses indicating that he had administered an influenza vaccination booster to each horse on 15 March 2018 and in relation to another horse a tetanus booster, when in fact he had administered the vaccination boosters on 21 March 2018, and that his conduct was misleading, dishonest and undermined the integrity of a vaccination process designed to promote animal welfare.
The third charge was that, on or around 21 March 2018, Dr Jones failed to make any entries in the clinical records for a horse in relation to an examination on 21 March 2018.
At the outset of the hearing Dr Jones admitted the facts in the first and second charges, and accepted that his actions were misleading, dishonest and that they undermined the integrity of a vaccination process. However, he disputed certain aspects of the written statements of the College’s witnesses. In particular he wanted his conduct to be taken in the context of the pressures that he was working under on that day, primarily that he was in a stressed state having had to euthanase a valuable stallion at the conclusion of his previous client appointment.
Dr Jones did not admit the third charge, explaining that he did not remember examining the horse on 21 March 2018 as alleged.
Based on Dr Jones' own admissions, the Committee found the first and second charges proven.
Regarding the third charge, the Committee heard evidence from the horse’s owner who said they were present during the examination taking place and the Committee was satisfied that the respondent did examine the horse on 21 March 2018 and that he had a duty to make a brief clinical note on the examination. As Dr Jones admitted that he made no such note, the Committee found the charge to have been proven to the requisite standard.
Having found the charges proven, the Committee then went on to consider whether or not Dr Jones’ proven conduct amounted to serious professional misconduct. The Committee, having considered the aggravating and mitigating factors, found that Dr Jones’ conduct as found proved in relation to both charges one and two, did constitute serious professional misconduct.
However, with regards to charge three, the Committee accepted that the respondent simply forgot that he had examined the horse and, therefore, the Committee was not satisfied that the failure to compile a record entry covering the horse’s examination constituted serious professional misconduct.
The Committee then considered what sanction to impose on Dr Jones in relation to the facts found proven in charges one and two. In doing so it took into account the 78 written testimonials and 4 character witnesses called on behalf of Dr Jones.
Ian Green, who chaired the Committee and spoke on its behalf, said: "The Committee’s decision on sanction has been based on an acceptance that the respondent’s conduct on this occasion was out-of-character, as the evidence of his character witnesses and the contents of the letters submitted in his support by his clients and other veterinary colleagues assert. The Committee also accepts that the respondent self-reported himself to his employer and to the College and has made a full and frank admission of his wrongdoing.
"Consideration was given to whether the sanction of a reprimand and/or warning as to future conduct would adequately reflect the gravity of the misconduct, however, after careful reflection it was concluded that such a sanction could not be justified. The reason is that acts of falsification involve acts of dishonesty by a professional person acting in a professional capacity, and the gravity of the matter arises not simply from the dishonesty but also from the possible consequences of the false certification. It should be clearly understood by members of the veterinary profession that, in appropriate false certification cases, the sanction of removal from the Register is one which may well be imposed."
The Committee therefore decided that suspending Dr Jones from the Register for two months would be the most appropriate sanction.
Louise was one of the world’s leading emergency and critical care veterinary nurses and a huge influence on the thousands of vet professionals who encountered her through her lectures, practical guide books and journal papers.
The £2000 award was created to celebrate her life and ensure that her passion for education continued to have a positive impact on the profession. It is awarded to the individual who has best demonstrated a commitment to making a difference in his or her chosen discipline, while continuing Louise's passion for shared learning.
Entries were judged by Vets Now’s clinical director Amanda Boag and senior RVNs Racheal Marshall and Arlene Connor. The winner was announced at the Vets Now ECC Congress in Leeds.
Lesley said: "I was already a little emotional when Amanda announced I’d won.
"I knew Louise and it’s still very hard to come to terms with the fact she isn’t here anymore. I think anyone who was at the gala dinner could see I was a bit overwhelmed when I got to the stage.
"I don’t think there are any nurses out there that didn’t find Louise inspirational. I chaired her at BSAVA a couple of years ago and we were both quite nervous. It was my first time chairing and she put her nerves to one side to make sure I was ok.
"She always spoke with such eloquence. Whenever you had the pleasure of listening to her she had the ability to make you feel like she was talking directly to you. We both also love vintage styling and I was regularly envious of some of her beautiful dresses. We used to speak about that as much as we did about veterinary nursing!"
Lesley plans to spend the bursary on courses in emergency ultrasound scanning and toxicology. She also hopes to use it to fund a postgraduate certificate in veterinary education.
She added: “This will give me the skills to develop my teaching and lecturing abilities so I can continue to help other RVNs who love ECC as much as I do."
Amanda Boag, clinical director at Vets Now, said "Louise was a wonderful colleague, friend and mentor to so many vets and vet nurses and Lesley embodies everything she stood for and held dear. She is a very deserving winner of this award."
Congratulations, Lesley!
Photo shows Lesley Moore talking with Louise O’Dwyer at an event last year.
The raw pet food poster gives owners guidance on how to handle and prepare their pet’s meal when feeding a commercial raw pet food. The guinea pig one gives guidance on what owners need to feed their guinea pig to ensure good health and well-being. It is also available to download from: www.pfma.org.uk/the-importance-of-hay-poster-guinea-pigs.
The PFMA will be giving away free copies of both the posters, alongside a range of other fact sheets and posters, at the London Vet Show.
The Association is also offering veterinary nurses the chance to win a £100 high street shopping voucher by taking part in its annual survey focusing on health and feeding trends, which can be done here: www.surveymonkey.com/r/PFMALVS19
The survey closes on Sunday 17th November.
Dechra says Finilac inhibits prolactin secretion by the pituitary gland and therefore inhibits all prolactin-dependent processes, meaning it can also suppress lactation in bitches and queens.
Finilac, which contains cabergoline (50 microgram/ml), is presented as a liquid which can be given orally or in food. It is available in 3 ml, 10 ml, 15 ml and 25 ml bottles with 1 ml and 2.5 ml syringes included in every pack to ensure accurate dosing.
The dosage is 0.1 ml/kg bodyweight once daily for four to six consecutive days, depending on the severity of the clinical condition. Maximum inhibition of prolactin secretion is achieved after four to eight hours.
Dechra Brand Manager Carol Morgan said: "A false pregnancy can be a distressing condition for an animal and its owner so Finilac offers a fresh approach for cases with more severe symptoms that require veterinary intervention.
"It is easy to administer either directly into the mouth or by mixing with food and it doesn’t need to be transported or stored in the refrigerator, making it ideal as an ‘at home’ treatment that can be administered by owners."
The association has also compiled free access special collection on backyard poultry in the BSAVA library, including A nursing guide to back yard chickens, which is available until the end of December 2019.
The BSAVA's Q&As on avian influenza in backyard poultry are:
What is avian influenza?Avian influenza (AI) is highly contagious viral disease that affects both domestic and wild birds. AI viruses are usually classified into two categories: low pathogenicity avian influenza (LPAI), which typically causes no or very few clinical signs in poultry, and high pathogenicity avian influenza (HPAI) which typically causes high mortality rates in poultry1.
What are the clinical signs of disease in poultry?The type and severity of clinical signs displayed will be dependent upon the strain of the virus and the species affected; some species such as ducks and geese may show few clinical signs2.
How is the disease spread?Wild bird species are the natural host and reservoir for all types of avian influenza, naturally carrying the virus in their respiratory and intestinal tracts, commonly without developing signs of the disease1,3. The virus is predominantly spread via body secretions, both directly and indirectly2. Migratory birds (predominantly waterfowl and gulls) can spread the disease over a wide geographical area3.
Why is the winter a higher risk period for avian influenza? The UK is at increased risk of avian influenza from migrating birds during winter2. Furthermore, avian influenza viruses are able to survive for prolonged periods of time in the environment, particularly in low temperatures4.
How can I prevent my birds from contracting avian influenza?All keepers of poultry should ensure that they uphold good levels of biosecurity to prevent disease entering their flock. This includes:
maintaining good levels of hygiene and regularly disinfecting hard surfaces;
changing shoes before entering/leaving to avoid transferring faeces in/out of the poultry enclosure;
minimizing contact with wildlife by humanely controlling rodents and deterring wild birds. Contact with wild birds can be minimized by placing food and water in an enclosed area such as the coop, and preventing poultry from accessing ponds/standing water frequented by wild bird populations, for example by erecting temporary fencing;
where possible, keeping birds of different poultry species separate (e.g. ducks and geese should be separate from chickens).
Whilst it is important that all backyard keepers maintain good levels of biosecurity, it is particularly prudent for keepers in areas deemed at higher risk of an incursion of avian influenza. In Great Britain, a number of High Risk Areas (HRAs) have been identified based upon previous experience, scientific expertise and veterinary opinion, and are predominantly areas where large numbers of migratory wild birds gather. To find out whether you are in a HRA, use the interactive map.
What should I do if I suspect avian influenza?Avian influenza is a notifiable disease. If it is suspected, it must be reported immediately:
In England, contact the Defra Rural Services Helpline on 03000 200 301
In Wales, contact your local Animal and Plant Health Agency (APHA) office on 0300 303 8268
In Scotland, contact your local Field Services Office
For keepers in Northern Ireland, contact your local DVO.
Current estimates suggest that around 95,000 calves, 30 million chicks and 3,000 Billy kids are affected per year.
The new position calls for solutions based on the overarching principle that quality of life should take precedence over lifespan, with the longer-term aim to move away from the production of unwanted animals all together. In the meantime, the position calls for further research into solutions to reduce numbers of additional male offspring and for humane methods of killing surplus animals on-farm.
The dairy and egg industries have been advised to adopt a ‘3Rs’ (reduce, replace, refine) approach to the rearing and slaughter of animals which are surplus to the requirements of the specific industries. Reduction recommendations include selecting for sex (a technology used quite frequently within the dairy farming community) and increasing the length of time that an animal can produce milk through selective breeding.
In the absence of these options, the position recommends raising male offspring for meat, with the caveat that calves and billy goat kids should be raised within UK high welfare schemes only.
In the absence of any reduce or replacement options, veterinary experts advise that killing should be undertaken in the most humane way and that all the animal’s welfare needs must be addressed prior to slaughter.
In line with BVA’s sustainable animal agriculture position, this policy recommends that when animals are killed, every effort should be made to make sure that the carcass is used. For example, the carcasses of male chicks killed by controlled atmospheric stunning can be used in animal feed, such as for reptiles and birds of prey.
BVA Junior Vice President, James Russell (pictured right) said: "Unwanted male production animals in the dairy and meat industries are an ethical challenge on a number of levels. Firstly, for the producer who may have animals with little or no commercial value. Secondly, for the consumer who may find the notion of these unused animals a difficulty. Our new joint position is based around the principle of ‘a life worth living’ and looks at ways that the veterinary profession can work with the farming community to reduce the numbers of animals that this affects and ensure that high welfare is always front and centre.
"If slaughter of affected animals is undertaken humanely, it is not a welfare harm per se, but greater measures should be taken to make sure that these decisions are made with minimal carcass wastage and an eye to the economic, emotional and environmental impact at a farm level.
"With greater public understanding of ethical and animal welfare issues faced by the industry, the promotion of farm assurance schemes and further research into alternative breeding options such as selective sex technology, we hope to reduce these numbers and improve the welfare of the animals involved."
BCVA President, Professor David Barrett said: "The number of unwanted male dairy calves has fallen substantially in recent years, due in part to more efficient milk production meaning we now need fewer dairy cows to produce the same volume of milk, as well as the use of breeding technologies that mean we can select for female calves. Nevertheless, surplus males are still produced. Provided these calves’ welfare is protected they should become part of the meat production supply chain either as high-quality UK farm assured veal or beef."
"As we strive for improved sustainability and increase efficient use of resource in food production, we need to use every product from dairying, including calves that can be reared for meat. Our entire industry needs to work together to create a robust supply chains for high quality, farm assured British dairy beef and veal and we need to help consumers understand they should embrace these products. They are very different from intensively reared veal of the type produced in systems previously banned in the UK."
The first is that the College will allow veterinary surgeons and nurses to carry over some of the CPD hours they have accrued in 2019 into 2020, to smoothen the transition to an annual hourly requirement.
Vets will be allowed to carry over 25 hours and VNs 10 hours of accumulated CPD from 2019 through to 2020.
This will apply once, in 2020 only, and is only applicable to vets and VNs who have been CPD-compliant from 2017 to 2019 and have a surplus number of hours to carry over.
Secondly, the College is going to allow vets and VNs to take a six-month 'CPD pause' for planned periods away from work, such as parental leave, and exceptional circumstances, such as serious ill health or unforeseen changes to family responsibilities, without the need to make up the hours when they return to work. This will reduce the burden on vets and VNs returning to work after a break.
RCVS Director of Education, Dr Linda Prescott-Clements said: "We hope that these changes to the CPD policy will support vets and VNs to make the transition to an annual hourly requirement.
"We received a sample of feedback from some members of the veterinary professions regarding the move to annual hourly CPD requirements and these additions have been introduced support members during this transition and to mitigate some of the concerns raised."
For more information about the CPD requirement for both vets and vet nurses, what activities might count as CPD, how to record your CPD and a series of frequently asked questions about CPD please visit our dedicated page: www.rcvs.org.uk/cpd.
The study, published in Nature Scientific Reports, investigated the effect of culling in the first three licensed badger cull areas – Gloucestershire, Somerset and Dorset – using data from 2013 to 2017.
Gloucestershire and Somerset saw reductions in bTB incidence rates in cull areas relative to comparison areas of 66 per cent and 37 per cent respectively after four years. In Dorset, there was no change in incidence rates in cull areas relative to comparison areas after two years, but incidence dropped by 55 per cent in the same period in the 2km buffer zone around the edge of the cull area. Matched comparison areas were similar but not identical.
James Russell, BVA Junior Vice President said: "These findings are encouraging and offer further evidence that badger culling can result in significant reductions in the number of new cases of TB in cattle. However, they come with the caveat that the data only relates to the first three cull areas, and the variability within these alone makes it too early to draw firm conclusions that culling will reduce incidence significantly in all 40 areas where it is now taking place.
"BVA’s expert working group is currently considering all aspects of disease control looking at cattle testing, removal of reactors, compensation and control in other farmed animals as well as the culling and vaccination of badgers. The group will consider this additional evidence as we develop our new policy on bTB.
"We continue to support a comprehensive and evidence-based approach to tackling bTB, including the use of badger culling where there is a demonstrated need and where it is done safely, humanely and effectively as part of a comprehensive strategy.
"The best way of halting the spread of this devastating disease is enhancing our understanding of bTB and applying that evidence to the eradication process.”
Although microchipping has been a legal requirement for dogs since April 2016, it is not currently required for cats unless they are travelling under the Pet Travel Scheme.
Cats Protection says microchipping should become a legal requirement for owned cats and is petitioning for change in the law. At the moment, it says, eight out of ten stray cats taken in by its adoption centres in England are not microchipped, making it virtually impossible to trace the owner.
Cats Protection’s Chief Executive, James Yeates, said: "Introducing compulsory microchipping of owned cats would encourage more cat owners to microchip their cats, meaning that lost cats can be identified and returned home rather than handed into rehoming charities as strays.
"It also means that injured cats can be quickly identified by vets and their owners can be informed and involved in their care.
"We’re delighted the Government has shown a commitment towards improving feline welfare and promoting responsible cat ownership in the UK by announcing this call for evidence."
Environment Secretary, Theresa Villiers, said: "Today’s call for evidence on cat microchipping will help the government understand how we can better protect this country’s much-loved cats and kittens. This government is committed to animal welfare and improving the lives of our companion animals."
The call for evidence will last for 12 weeks and respondents are being encouraged to respond as soon as possible. You can take part here.
The company says a combination of unprecedented demand for the product and logistics issues, together with an issue involving the manufacturer of the active ingredient, has resulted in a delay in receiving stock into the UK.
Animalcare says it has a shipment awaiting dispatch to the UK from its European manufacturing plant as soon as licensing is completed by the VMD, Home Office and European counterparts. There is another batch in production, expected into the UK in early March.
Kai Crawshaw, Product Manager at Animalcare, said: "We are working hard with the VMD and Home Office to expedite the import licensing process and also with our manufacturer to ensure we can get as much stock as quickly as possible back into the marketplace. We sincerely apologise to any clinics that are experiencing a shortage but are glad to say that stock is on the way."
In the study, Fluorescent tagging for environmental surface cleaning surveillance in a veterinary hospital 1, researchers at Ohio State University used a fluorescent dye to tag pre-determined surfaces in a large veterinary teaching hospital.
The dye was invisible to the naked eye, but fluoresced under a blacklight (UV-A source). It could be easily removed by regular cleaning.
Surfaces were tagged and then assessed 24 hours after tag placement to determine whether they had been cleaned. Tagging and assessment took place during non-peak hours in an attempt to eliminate observer bias. The study ran for a period of 5.5 weeks between June and July 2014 and a total of 4984 surfaces were tagged and assessed.
Jason Stull, corresponding author of the paper said: "Overall, 50% of surfaces were adequately cleaned so that the tag was completely removed. Cleaning varied widely by surface/object and hospital location. Of the surfaces designated as having primarily human contact, the equipment cart and door handle to the dog walking area were most frequently cleaned (100%), whilst examination equipment including the otoscope, ophthalmoscope and swivel light handle were the least frequently cleaned (2.3%).
"Of the surfaces designated as having primarily animal contact, the ward cage interior was the most frequently cleaned (89.0%) whilst the dog run interior was the least frequently cleaned (23.1%). In terms of hospital location, the most frequently cleaned area was radiology (77.5%) and the least frequently cleaned area was the small animal treatment area (4.2%)."
The overall proportion of surfaces satisfactorily cleaned was similar to that reported in previous studies, however, the findings for some surfaces and hospital areas differed.2 This demonstrates the importance of veterinary cleaning surveillance in individual practices so that targeted interventions can be implemented.
Nicholas Jeffery, editor of JSAP said: "With health-care associated infections being a persistent problem in human and veterinary medicine, it is important that surfaces and equipment within the veterinary practice are adequately cleaned. This research demonstrates the potential use of a commercial fluorescent dye for veterinary cleaning surveillance to inform hospital cleaning practices."
The full article can be found in the February issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13090
Licensed for use from 6 weeks of age - and in pregnant and lactating bitches and queens - Evicto provides adulticidal, larvicidal and ovicidal flea protection, which can also help to control environmental flea infestations in areas where the pet has access. It also treats ear mites, biting lice, intestinal roundworms, sarcoptic mange in dogs, intestinal hookworms in cats and can be used to prevent heartworm disease with monthly administration.
Evicto is presented in packs of 4 pipettes which are transparent so owners can see that the full dose has been applied. The company also highlights that with Evicto pets can be bathed 2 hours after treatment without loss of efficacy.
Claire Lewis, Product Manager at Virbac said: "We are pleased to add Evicto to our award-winning range of parasite protection products.
"Evicto can also be used concurrently with Milpro, making it the perfect product partnership."
Evicto is available from the veterinary wholesalers now.
For information, speak to your Virbac Territory Manager.
The campaign will highlight things that can be done to help anxious pets, including getting professional advice from a behaviourist or trainer and using the company's products.
There's a marketing pack for practices, to help you educate owners and promote the month. It includes bunting, wall displays, posters, leaflets and gift vouchers for pet owners.
To raise awareness, Ceva will also be running a PR and advertising campaign together with a social media initiative in which owners will be encouraged to share their experience of having an anxious pet on Instagram and Facebook.
Abigail King, senior product manager at Ceva said: "It is widely known that humans suffer from anxieties, but pets do too with 82% of dogs and 89% of cats reported to be scared of something1.
"It is therefore important that we educate pet owners on the signs of stress and the help and support that they can give to their pets.
"Pet Anxiety Month will get people talking and we want people to know that there are products out there to support pets and that help is at hand to get the right advice, which is extremely important."
For further information, visit the Pet Anxiety Month website or follow the campaign on Instagram and Facebook. To request the Pet Anxiety Month marketing pack, email cevauk@ceva.com.